Nanotechnology, Cancer, Health Technology, Medical Technology, Innovation.
distinguish between healthy and diseased tissues. Having fewer targeting molecules makes the nanocarrier more selective, as it will have a harder time binding to healthy tissue where the corresponding biomarkers are not over-expressed. The team’s new study adds new dimensions to the model of the